Women are often the pillars of their immediate families, surrounding communities, and the wider economic landscapes. So why can women’s health end up being deprioritised when we need it emphasised?
Kenya has among the highest mortality rates of breast cancer globally, with eighty percent of women diagnosed unlikely to survive beyond five years1.
Changing this narrative was the challenge taken on by the Roche Kenya team. Engaging with the
Creating robust solutions starts with thoroughly defining the problem, so our first step was to conduct extensive research. A number of major gaps in breast cancer care emerged:
Awareness: many women in Kenya were not aware of what symptoms to look out for
Treatment: only few specialised healthcare providers and treatment centres existed, and those that did were few and far between, mostly in larger cities
Reimbursement: there was an absence of institutional financial support, meaning patients often had to bear significant out-of-pocket treatment costs
These factors combined meant women with breast and cervical cancer were often seeking medical help late, occasionally only at advanced stages of cancer, or in some cases not having the right tools to seek help at all. Armed with a deeper understanding of the challenges, the team knew it was time to bring together a league of extraordinary organisations to create a system with a lasting impact.
The shift began with raising awareness and building visibility of breast cancer at the community level. “We partnered with the
To improve the standard of breast cancer care at the clinical level, where treatment and observation of the patients take place, we collaborated with the
Finally, we formed collaborations with the Kenya National Health Insurance Fund and, with assistance from the Ministry of Health Kenya, we catalysed comprehensive policy reforms to ensure that patients had access to reimbursement for the entire duration of breast cancer treatment.
Many patients had been paying for treatment out of pocket. It was critical we brought in government bodies to ensure there’s accountability from their side in upholding our constitution of providing health for all.
Thanks to our impactful partnerships, 19 specialised EMPOWER clinics have been established in Kenya since 2019, providing breast and cervical cancer screening to over 132,000 women throughout the country2.
Awareness of breast cancer has improved massively, and with specialist clinics that are more widespread and accessible, the wait time from diagnosis to treatment has dropped from on average 18-24 months, to 3-6 months.
But the impact does not stop there. Men accompanying women were also educated about their health, resulting in over 4,000 screenings for prostate cancer and its inclusion as a core service. This also inspired an integrated approach that facilitated screening for over 17,000 patients for diseases such as diabetes and hypertension2.
Women with concerns around breast cancer – as well as cervical cancer which is also covered by the EMPOWER clinics – are presenting to the healthcare system earlier, with a better understanding of their symptoms. With reimbursement in place, they can complete the full 18 cycles of treatment, giving them a chance to have improved health outcomes and allowing them to spend more time with their families and communities.
Together with partners across government entities, healthcare bodies, and community-oriented organisations, we aim to change healthcare systems by understanding the patient journey thoroughly.
References
Matheka M, Mutebi M, Sayed S, Shaikh AJ. Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre. ecancer. 2023;17:1566.
Global Health Progress. EMPOWER clinics Kenya [Internet; cited 2024 Apr]. Available from: